Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 362


Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.

Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C, Berrios E, Harrington RA, Ohman EM, et al.

Circulation. 1995 Apr 1;91(7):1929-35.


Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.

Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD.

Thromb Haemost. 2001 Oct;86(4):991-4.


Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.

Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.

Eur Heart J. 1996 Aug;17(8):1207-15.


Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.

Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ.

J Am Coll Cardiol. 2002 Mar 6;39(5):811-7.


Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.

Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.

Eur Heart J. 2000 Sep;21(17):1473-81.


Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease.

Oldgren J, Linder R, Grip L, Siegbahn A, Wallentin L.

Eur Heart J. 1999 Nov;20(22):1657-66.


Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.

Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB, et al.

J Am Coll Cardiol. 1993 Apr;21(5):1039-47.


Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

Vila V, Martínez-Sales V, Réganon E, Peris E, Perez F, Ruano M, Aznar J.

Haematologica. 2001 Jul;86(7):729-34.


Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial.

Giugliano RP, Wiviott SD, Stone PH, Simon DI, Schweiger MJ, Bouchard A, Leesar MA, Goulder MA, Deitcher SR, McCabe CH, Braunwald E; ANTHEM-TIMI-32 Investigators.

J Am Coll Cardiol. 2007 Jun 26;49(25):2398-407. Epub 2007 Jun 11.


Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.

Galvani M, Abendschein DR, Ferrini D, Ottani F, Rusticali F, Eisenberg PR.

J Am Coll Cardiol. 1994 Nov 15;24(6):1445-52.


Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.

Watkins MW, Luetmer PA, Schneider DJ, Witmer WT, Vaitkus PT, Sobel BE.

Cathet Cardiovasc Diagn. 1998 Jul;44(3):257-64.


Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes.

Merlini PA, Ardissino D, Bauer KA, Oltrona L, Pezzano A, Bottasso B, Rosenberg RD, Mannucci PM.

Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1325-30.


Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.

Smith AJ, Holt RE, Fitzpatrick JB, Palacios IF, Gold HK, Werner W, Bovill EG, Fuster V, Jang IK.

Am Heart J. 1996 Mar;131(3):434-9.


Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment.

Andersen K, Dellborg M, Emanuelsson H, Grip L, Swedberg K.

Coron Artery Dis. 1996 Sep;7(9):673-81.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk